Search research articles
Contact Us
Filters
Showing results (541-550 of 1,833) with videos related to
Page
of 184
Sort By:
Mabs
|
September 1, 2025
A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia
Hollie B S Griffiths, Nyle Jones, Mattia Vitale, et al.
Mabs
|
June 18, 2015
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
Emily C Piccione, Silvia Juarez, Jie Liu, et al.
Mabs
|
June 4, 2020
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
Amita Datta-Mannan, Selina Estwick, Chen Zhou, et al.
Mabs
|
August 12, 2021
An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics
Norbert Furtmann, Marion Schneider, Nadja Spindler, et al.
Mabs
|
August 4, 2021
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
Mabs
|
August 9, 2021
Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development
Rosalynn Molden, Mengqi Hu, Sook Yen E, et al.
Mabs
|
May 17, 2021
Collecting antibodies and large molecule biomarkers in mouse interstitial brain fluid: a comparison of microdialysis and cerebral open flow microperfusion
Florie Le Prieult, Erica Barini, Loic Laplanche, et al.
Mabs
|
August 2, 2022
Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic
Maria Myzithras, Siqi Lin, Legairre Radden, et al.
Mabs
|
August 26, 2022
Full-length recombinant antibodies from <i>Escherichia coli</i>: production, characterization, effector function (Fc) engineering, and clinical evaluation
Md Harunur Rashid
Mabs
|
June 7, 2015
A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus
Peng Du, Lei Xu, Weiyi Qiu, et al.
Page
of 184
Search research articles
Search
Showing results (541-550 of 1,833) with videos related to
Sort By:
Page
of 184
Mabs
|
September 1, 2025
A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia
Hollie B S Griffiths, Nyle Jones, Mattia Vitale, et al.
Mabs
|
June 18, 2015
A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
Emily C Piccione, Silvia Juarez, Jie Liu, et al.
Mabs
|
June 4, 2020
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
Amita Datta-Mannan, Selina Estwick, Chen Zhou, et al.
Mabs
|
August 12, 2021
An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics
Norbert Furtmann, Marion Schneider, Nadja Spindler, et al.
Mabs
|
August 4, 2021
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
Parul Gupta, Ziyue Karen Jiang, Bing Yang, et al.
Mabs
|
August 9, 2021
Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development
Rosalynn Molden, Mengqi Hu, Sook Yen E, et al.
Mabs
|
May 17, 2021
Collecting antibodies and large molecule biomarkers in mouse interstitial brain fluid: a comparison of microdialysis and cerebral open flow microperfusion
Florie Le Prieult, Erica Barini, Loic Laplanche, et al.
Mabs
|
August 2, 2022
Development of novel ultra-sensitive IL-11 target engagement assays to support mechanistic PK/PD modeling for an anti-IL-11 antibody therapeutic
Maria Myzithras, Siqi Lin, Legairre Radden, et al.
Mabs
|
August 26, 2022
Full-length recombinant antibodies from <i>Escherichia coli</i>: production, characterization, effector function (Fc) engineering, and clinical evaluation
Md Harunur Rashid
Mabs
|
June 7, 2015
A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus
Peng Du, Lei Xu, Weiyi Qiu, et al.
Page
of 184